Literature DB >> 19270506

The multiple mechanisms of amyloid deposition: the role of parkin.

Maria A Mena1, José A Rodríguez-Navarro, Justo García de Yébenes.   

Abstract

Amyloid deposition is one of the central neuropathological abnormalities in Alzheimer's disease (AD) but it also takes places in many neurodegenerative diseases such as prionic disorders, Huntington's disease (HD) and others. Up to very recently amyloid formation was considered a very slow process of deposition of an abnormal protein due to genetic abnormalities or post-translational modification of the deposited protein. Recent data suggest that the process of amyloidogenesis may be much more rapid in many cases and due to multiple mechanisms. We have found a mouse model of progressive neurodegeneration that resemble motor, behavioral and pathological hallmarks of parkinsonism and tauopathies, but surprisingly, also present amyloid deposits in brain and peripheral organs. Here we review some of these recent works which may provide new insight into the process of formation of amyloid and, perhaps, new ideas for its treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270506      PMCID: PMC2676737          DOI: 10.4161/pri.3.1.8122

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  87 in total

Review 1.  Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jorge A Fernández; Andrea A Maccioni; José M Jimenez; Ricardo B Maccioni
Journal:  Arch Med Res       Date:  2007-10-31       Impact factor: 2.235

2.  Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway.

Authors:  James A Olzmann; Lih-Shen Chin
Journal:  Autophagy       Date:  2007-10-15       Impact factor: 16.016

3.  Degradation of nicastrin involves both proteasome and lysosome.

Authors:  Guiqiong He; Hong Qing; Yigang Tong; Fang Cai; Shoichi Ishiura; Weihong Song
Journal:  J Neurochem       Date:  2007-02-26       Impact factor: 5.372

4.  CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism.

Authors:  Pravir Kumar; Rashmi K Ambasta; Vimal Veereshwarayya; Kenneth M Rosen; Ken S Kosik; Hamid Band; Ruben Mestril; Cam Patterson; Henry W Querfurth
Journal:  Hum Mol Genet       Date:  2007-02-22       Impact factor: 6.150

5.  Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.

Authors:  Salvatore Oddo; Antonella Caccamo; David Cheng; Bahareh Jouleh; Reidun Torp; Frank M LaFerla
Journal:  J Neurochem       Date:  2007-04-30       Impact factor: 5.372

6.  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Authors:  Erik D Roberson; Kimberly Scearce-Levie; Jorge J Palop; Fengrong Yan; Irene H Cheng; Tiffany Wu; Hilary Gerstein; Gui-Qiu Yu; Lennart Mucke
Journal:  Science       Date:  2007-05-04       Impact factor: 47.728

7.  A primer of amyloid nomenclature.

Authors:  Per Westermark; Merrill D Benson; Joel N Buxbaum; Alan S Cohen; Blas Frangione; Shu-Ichi Ikeda; Colin L Masters; Giampaolo Merlini; Maria J Saraiva; Jean D Sipe
Journal:  Amyloid       Date:  2007-09       Impact factor: 7.141

8.  Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.

Authors:  Shingo Ito; Sumio Ohtsuki; Junichi Kamiie; Yasuko Nezu; Tetsuya Terasaki
Journal:  J Neurochem       Date:  2007-10-01       Impact factor: 5.372

Review 9.  Impact of recent genetic findings in Parkinson's disease.

Authors:  Christine Klein; Katja Lohmann-Hedrich
Journal:  Curr Opin Neurol       Date:  2007-08       Impact factor: 5.710

10.  Mortality, oxidative stress and tau accumulation during ageing in parkin null mice.

Authors:  Jose A Rodríguez-Navarro; M José Casarejos; Jaime Menéndez; Rosa M Solano; Izaskun Rodal; Ana Gómez; Justo García de Yébenes; Maria A Mena
Journal:  J Neurochem       Date:  2007-07-10       Impact factor: 5.372

View more
  3 in total

Review 1.  Roles of Heme Oxygenase-1 in Neuroinflammation and Brain Disorders.

Authors:  Yi-Hsuan Wu; Hsi-Lung Hsieh
Journal:  Antioxidants (Basel)       Date:  2022-05-08

2.  A concise review of amyloidosis in animals.

Authors:  Moges Woldemeskel
Journal:  Vet Med Int       Date:  2012-03-15

3.  SAGA DUB-Ubp8 Deubiquitylates Centromeric Histone Variant Cse4.

Authors:  Claudia Canzonetta; Stefano Vernarecci; Michele Iuliani; Cristina Marracino; Claudia Belloni; Paola Ballario; Patrizia Filetici
Journal:  G3 (Bethesda)       Date:  2015-11-27       Impact factor: 3.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.